Microenvironmental transformations by VEGF- and EGF-receptor inhibition and potential implications for responsiveness to radiotherapy-Reference-Cited by-同舟云学术

Microenvironmental transformations by VEGF- and EGF-receptor inhibition and potential implications for responsiveness to radiotherapy

Published:2007-01 Issue:1 Volume:82 Page:10-17
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Bussink Johan,Kaanders Johannes H.A.M.,van der Kogel Albert J.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference88 articles.

1. Constitutive expression of hypoxia-inducible factor-1{alpha} renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation;Akakura;Cancer Res,2001

2. Modulation of oxygen consumption rate and vascular endothelial growth factor mRNA expression in human malignant glioma cells by hypoxia;Allalunis-Turner;Br J Cancer,1999

3. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma;Ang;Cancer Res,2002

4. Akt and hypoxia-inducible factor-1 independently enhance tumor growth and angiogenesis;Arsham;Cancer Res,2004

5. Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver;Arteel;Br J Cancer,1995

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reversing lung cancer radioresistance by hyperpermeable tellurium nanotherapeutics via remodeling tumor microenvironment;Nano Today;2023-06

2. 3-Bromopyruvate Suppresses the Malignant Phenotype of Vemurafenib-Resistant Melanoma Cells;International Journal of Molecular Sciences;2022-12-09

3. Advances in receptor modulation strategies for flexible, efficient, and enhanced antitumor efficacy;Journal of Controlled Release;2021-05

4. Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy;Signal Transduction and Targeted Therapy;2021-01-12

5. HS-173, a selective PI3K inhibitor, induces cell death in head and neck squamous cell carcinoma cell lines;Wiener klinische Wochenschrift;2020-09-02